The antibiotic kanosamine inhibited growth of Saccharomyces cerevisiae and a range of human pathogenic fungi, including Candida albicans. Kanosamine was transported into C. albicans cells by the glucose transport system and subsequently phosphorylated. The product of its intracellular metabolism, kanosamine-6-phosphate, was an inhibitor of the enzyme glucosamine-6-phosphate synthase. Inhibition was competitive in respect to one of the substrates, D-fructose-6-phosphate, with K iˆ5 ¢9 mM, and was non-competitive in respect to the second substrate, L-glutamine. On the other hand, kanosamine-6-phosphate had no effect on the enzyme catalysing the next metabolic step, namely glucosamine-6-phosphate Nacetylase. The action of kanosamine on C. albicans cells resulted in profound morphological changes, inhibition of septum formation and cell agglutination. Experiments with S. cerevisiae mutants showed that the presence of the Cdr1p drug ef ux pump did not affect the antifungal activity of kanosamine.
Introduction
Disseminated fungal infections remain one of the major problems in modern chemotherapy. Only a very limited number of antifungal agents are used in clinical practice, including the highly toxic amphotericin B as a 'gold standard' and less toxic but also less effective synthetic compounds, uconazole and itraconazole [1] . The emerging challenge of multi-drug resistance (MDR) makes the situation even worse. Thus searching for alternatives for existing drugs is an urgent need. In this respect, it is worth re-evaluating some antibiotics which have not found clinical application but which have some properties making them interesting starting points for new drug development.
Kanosamine, 3-amino-3-deoxy-D-glucose, was rst isolated as one of the products of acid hydrolysis of kanamycin [2] , but later the same compound was identi ed as an antibiotic produced by Bacillus aminoglucosidicus [3] . The antibiotic was reported to exhibit some antibacterial in vitro activity [3] but very high minimal inhibitory concentrations (MICs) and narrow antibacterial spectrum precluded its further development. More recently, a strong inhibitory effect of kanosamine on growth of some plant-pathogenic fungi and oomycetes was demonstrated [4] . Studies on the mechanism of antibacterial action of kanosamine revealed that the antibiotic inhibited cell wall biosynthesis [5] . It was suggested that a product of possible intracellular metabolism of kanosamine might be an inhibitor of one of the enzymes catalysing the initial reactions of the hexosamine biosynthetic pathway [6] . However, the actual target has not been identi ed unequivocally.
In this paper we present studies on the antifungal action of kanosamine, aimed at identi cation of the actual kanosamine metabolite and its intracellular target. Prasad, Jawaharlal Nehru University, New Delhi, India. Both yeast mutants were propagated as described previously [7] .
Chemicals
Kanamycin, yeast hexokinase and RPMI 1640 medium were from Sigma-Aldrich (St. Louis, Missouri, USA). Dowex 50 WX 8 and 1X8 resins were from Serva Feinbiochemica, Heidelberg, Germany. Other reagents were of the highest grade commercially available.
Isolation of kanosamine
Two methods of preparation of kanosamine were used. A small amount of the antibiotic for analytical purposes was isolated from fermentation broth of B. aminoglucosidicus, essentially as described previously [3] . Alternatively, a bulk amount of kanosamine was isolated from acid hydrolysate of kanamycin according to our modi cation of the previously published procedure [2] . Kanamycin, 300 mg, was hydrolysed with 6 M HCl at 60 o C for at least 2 h. The resulting hydrolysate was fractionated by thin layer chromatography (TLC) on silica gel plates, using solvent system 1 (n-butanol-acetic acid-H 2 O, 4:1:1). Compounds containing amino groups were detected using the ninhydrin reagent. After evaporation at reduced pressure, the solid residue was re-dissolved in solvent system 2 (n-butanol-acetic acid-H 2 O, 4:2:1) and the resulting solution was chromatographed on a cellulose column developed with the same solvent system. Fractions which showed a single ninhydrin-positive spot on TLC plates developed with solvent system 1 (R fˆ0 ¢28) were collected and evaporated. The solid residue was dissolved in water and passed through the Dowex 50 WX 8 (H ‡ ) column. Pure kanosamine hydrochloride was eluted with 40 mM HCl. The solution was lyophilized to give a very hygroscopic white powder. The nuclear magnetic resonance (NMR) spectrum was consistent with the expected structure. The melting point and chromatographic properties were identical with those of the B. aminoglucosidicus fermentation product and with those published in the literature [2, 3] . 4 (speci c for polyols) [9] . When the reaction was completed after 12 h, the Hanes-, ninhydrin-and aniline phthalate-positive product was isolated by means of consecutive ion-exchange chromatography on Dowex 1X8 (OH ¡ ) and Dowex 50WX8 (H ‡ ) columns and lyophilized to give 40 mg of a white powder. The puri ed compound had the following properties: TLC data, R f0 ¢14 in solvent system 1, R fˆ0 ¢55 in solvent system 3; NMR spectral data (Dˆdeuterium; dˆchemical shift; mˆmultiplet; sˆsinglet; Hˆhydrogen; Pp hosphorus), 
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1 H NMR (D 2 O), d : 3¢50 (m, 1H), 3¢59 (m, 2H), 3¢82 (m, 1H), 3¢97 (m, 3H); 31 P NMR (D 2 O), d : 1¢4 (s, 1P).
Metabolism of kanosamine in cell free extract
Kanosamine was added to the cell-free extract, prepared from C. albicans ATCC 10261 cells as described previously [10] , to give a nal concentration of 5 mg ml
¡1
. The mixture was incubated at 30 o C and 1 ml samples were collected hourly and de-proteinized by addition of 1 ml of ethanol. Precipitates were removed by ltration and the course of reaction was followed by TLC analysis of the ltrates (solvent system 1). Alternatively, C. albicans ATCC 10261 cells were grown in YNB liquid medium at 30 o C in the presence or absence of kanosamine, 1 mg ml
. Antibiotic was added when the density of the cell suspension measured at lˆ660 nm reached 0¢6. At hourly time intervals samples of the cell suspension were collected, cells were harvested by centrifugation and broken by the smallscale glass beads procedure [11] . Crude extracts were analysed for the activity of glucosamine-6-phosphate (GlcN-6-P) synthase and GlcN-6-P N-acetylase and by TLC (solvent system 1, aniline phthalate spray reagent), as described above.
Isolation of the kanosamine metabolite
C. albicans cells from the overnight culture in YNB were harvested by centrifugation and suspended in 100 ml of the fresh YNB medium, to the cell density of 10 8 cells ml
¡1
. Kanosamine was added to the nal concentration of 1 mg ml
, and the cell suspension was incubated for 6 h at 30 o C. Cells were then harvested, washed with cold distilled water, suspended in a minimal amount of water and broken with a French press. Cellular debris was removed by centrifugation (3000g, 15 min, 4 o C). The supernatant was de-proteinized by heating (5 min, 100 o C). Components of the resulting solution were separated by ion-exchange chromatography, essentially as described above for the isolation of kanosamine-6-phosphate prepared by enzymatic synthesis. Fractions containing a substance identical with kanosamine, as determined by TLC analysis, were combined and lyophilized. The white product was analysed by NMR.
GlcN-6-P synthase puri®cation and determination of enzymatic activity.
C. albicans GlcN-6-P synthase overproduced by S. cerevisiae YRS C-65 was puri ed to homogeneity as described previously [10] . Enzymatic activity was determined by the modi ed Elson-Morgan procedure [12] . Reactions were carried out in 25 mM phosphate buffer pH 6¢9, containing 1 mM EDTA and 1 mM dithiothreitol. D-Fructose-6-phosphate and L-glutamine concentrations were either xed (7¢5 mM and 10 mM respectively, for general activity and for determination of concentrations inhibiting 50% of enzymatic activity [IC 50 ]) or variable (0¢5-7¢5 mM and 0¢625-10 mM respectively), for inhibitory constants (K i ) determinations. K i values were then determined from the secondary plots of apparent Michaelis constants vs. inhibitor concentration, derived from Lineweaver-Burk plots.
Determination of activity of GlcN-6-P N-acetylase
Activity of this enzyme was determined in crude extracts prepared as described above from C. albicans ATCC 10261 cells, according to the previously described procedure [13] . Morphological changes of C. albicans cells upon the action of kanosamine were documented by photomicrographs using the Olympus BX 60 F5 microscope (Olympus Optical Co., Shinjuku-ku, Tokyo, Japan). Protein was determined by the Bradford procedure [14] .
Other methods

Results and discussion
As the yield of kanosamine produced by the B. aminoglucosidicus strain was very low, we used the small amount of this compound as an analytical reference and decided to isolate kanosamine hydrochloride from the acid hydrolysate of kanamycin. For this purpose we elaborated a puri cation procedure which afforded 180 mg of pure kanosamine hydrochloride from 1500 mg of kanamycin. The NMR data for the isolated compound were consistent with the expected structure. TLC analysis and melting point were in agreement with values reported previously for kanosamine hydrochloride (R fˆ0 ¢28; solvent system 1, m.p. 120 o C (decomposition) [3] . The previous literature data on biological properties of kanosamine con rmed the antibacterial activity of this compound [4] . We found that kanosamine inhibited growth of some fungi, but the minimal inhibitory concentration values determined by the microplate broth dilution method in minimal YNB medium containing 1% glucose and in buffered RPMI 1640 medium were very high (Tab. 1). Similar values were found when the experiment was performed in Sabouraud medium (data not shown). The presence of 10 mM N-acetyl-D-glucosamine (GlcNAc) completely abolished the growth inhibitory effect of kanosamine, while N-acetyl-Dmannosamine and N-acetyl-D-galactosamine had no effect.
In a separate experiment we compared the growth inhibitory activity of kanosamine against S. cerevisiae JG 436 and PS 124 cells. The JG 436 cells have a disrupted PDR5 gene, which normally encodes the major drug extruding protein of yeast. The PS 124 cells are derived from JG 436, but have been transformed with a plasmid containing the CDR1 gene encoding the C. albicans analogue of Pdr5p [7] . Exactly the same MIC values were noted for both JG 436 and PS 124 ( Table 1) , demonstrating that the presence of the Cdr1p drug ef ux pump does not affect the antifungal activity of kanosamine in vitro.
The microscopic examination of cells treated with kanosamine revealed morphological changes characteristic for yeast cells affected by compounds inhibiting chitin and/or mannoprotein biosynthesis. These alterations included cell agglutination, visible destruction of cell integrity, cell swelling and inhibition of septum formation (Fig. 1) . Similar morphological changes were previously described as a result of the action of oligopeptides containing an inhibitor of GlcN-6-P synthase [15] . On the other hand, nikkomycins and polyoxins, known inhibitors of chitin synthase, inhibit septum formation and cause cell swelling and lysis [16, 17] while tunicamycin, a selective inhibitor of mannoprotein biosynthesis, causes mainly cell agglutination [18] . Uptake of low-molecular-weight compounds is usually measured by radiochemical methods. Since the radioactively labelled kanosamine was not available, we developed a chemical method allowing the colorimetric determination of kanosamine concentration. Kanosa- mine reacted with TNBS to give a yellow product. As the absorbance of the resulting solution measured at lˆ420 nm showed a linear dependence on kanosamine concentration in the 5-100 m g ml ¡1 range, this method could be validly used to determine the kanosamine concentration. Figure 2 shows [20] . They differ in a number of features but share one, i.e. they do not involve sugar phosphorylation in their mechanism of action [21] . It is possible that a similar situation exists in C. albicans.
Literature data suggests that kanosamine may be phosphorylated by yeast hexokinase [22] . We have developed conditions for enzymatic phosphorylation allowing an almost quantitative conversion of kanosamine into kanosamine-6-phosphate as well as a procedure for puri cation of the phosphorylated product (yield 90%). NMR data of the isolated compound were consistent with the structure of kanosamine-6-phosphate. The TLC analysis data were as follows: R fˆ0 ¢14 (solvent system 1), R fˆ0 ¢55 (solvent system 3). The phosphorylated compound at 20 mg ml ¡1 was completely ineffective when tested for antifungal activity. In previous papers on the mechanism of kanosamine's antibacterial action, it was suggested that this amino sugar could be phosphorylated during transport or in the cytoplasm [6] ; no evidence, however, was presented. In our studies we used TLC for semi-quantitative analysis of kanosamine metabolism in C. albicans cells treated with kanosamine, 5 mg ml
¡1
. Cells were harvested at time intervals and broken. Crude extracts were deproteinized by heating and remaining aliquots were examined by TLC using different colour-developing, speci c reagents. At zero time and after 1 h, only the spot corresponding to kanosamine could be detected (R fˆ0 ¢28, solvent system 1, nihydrin-and aniline phthalate-positive, Hanes-negative). However, the chromatograms of the samples collected at 2 h and thereafter showed another spot (R fˆ0 ¢14, solvent system 1, nihydrin-, aniline phthalate-and Hanes-positive). The chromatographic behaviour of the newly seen metabolite was identical with that of kanosamine-6-phosphate synthesized enzymatically in vitro. Conclusive con rmation was provided by NMR analysis of the isolated metabolite. The NMR spectrum of this compound was almost identical with that of kanosamine-6-phosphate prepared by enzymatic synthesis from kanosamine.
The spot corresponding to kanosamine-6-phosphate was also detected by TLC analysis of the crude extract prepared from C. albicans cells, incubated in vitro for several hours at 30 o C with kanosamine added at an initial concentration 5 mg ml
. Presence of kanosamine-6-phosphate was rst detected after 5 h. Therefore it is certain that kanosamine is phosphorylated at C6-OH by the cytoplasmic kinase within C. albicans, most likely by the hexokinase. The rate of this process is rather low. This is not surprising in light of the report of Machado de Domenech and Sols [22] , who noted that kanosamine was phosphorylated in vitro by yeast hexokinase at a rate only 0¢3% of that observed for D-glucose.
The structural analogy between kanosamine-6-phosphate and glucosamine-6-phosphate and reversal of antifungal action of kanosamine by GlcNAc suggested either L-glutamine: D-fructose-6-phosphate amidotrans- ferase (GlcN-6-P synthase) or GlcN-6-P N-acetylase as possible targets for kanosamine or its metabolite in C. albicans cells. These enzymes catalyse consecutive steps in a cytoplasmic pathway leading to the eventual formation of uridine-5 0 -diphospho-N-acetylglucosamine (UDP-GlcNAc) which, in turn, provides GlcNAc for the biosynthesis of the fungal aminosugar-containing cell wall macromolecules, chitin and mannoproteins. Therefore, kanosamine and kanosamine-6-phosphate were tested as potential inhibitors of both enzymes. Kanosamine did not inhibit GlcN-6-P synthase activity in crude extract prepared from C. albicans cells or in the studies using the pure enzyme. On the other hand, kanosamine-6-phosphate inhibited the enzyme. Inhibition of 50% of the enzymatic activity was observed at 9¢8 mM. Kinetic analysis of the inhibition, shown in Figure 3 , revealed that it was competitive with regard to Fru-6-P (K i5 ¢9 mM) and non-competitive with regard to m -Gln (K i2 1 mM). It is thus clear that kanosamine-6-phosphate interacts with the enzyme at the Fru-6-P binding site. It should be therefore mentioned that the natural product of the reaction catalysed by GlcN-6-P synthase, i.e. Dglucosamine-6-phosphate, was previously demonstrated to be an inhibitor of the bacterial enzyme [23] , with an inhibition pattern identical to that found by us for kanosamine-6-phosphate. On the other hand, neither kanosamine nor kanosamine-6-phosphate, 50 mM, inhibited GlcN-6-P N-acetylase activity. Inhibition of GlcN-6-P synthase was also demonstrated in C. albicans cells treated with kanosamine, 5 mg ml
. Figure 4 shows that the enzymatic activity determined in crude extracts of C. albicans progressively decreased with time, falling after 8 h to less than 50% of that noted for control cells. As mentioned above, the inhibitory effect of kanosamine on C. albicans was fully reversed by GlcNAc but not by other N-acetyl aminosugars. On the other hand, it is known that GlcNAc is transported into C. albicans by a speci c inducible permease and subsequently phosphorylated [24] . GlcNAc-6-P may then enter the catabolic pathway or supplement a possible intracellular shortage of aminosugars, thus overcoming the kanosamine-induced glucosamine depletion. Therefore, there is little doubt that GlcN-6-P synthase is the only target for kanosamine-6-phosphate in C. albicans cells, and is crucial for their growth and division.
Giordani et al. reported that 200 mM D-glucosamine caused a 25-35% inhibition of the growth of S. cerevisiae [25] . The authors explained that effect as a consequence of inhibition of the extracellular enzyme, N-acetyl-b -Dglucosaminidase. Inhibition of yeast growth on nonfermentable carbon sources by D-glucosamine was also demonstrated [26] . Despite the close structural analogy between D-glucosamine and kanosamine, the mechanism of antifungal action of the latter is very different. Our results clearly demonstrate that kanosamine is transported into fungal cells and phosphorylated in the cytoplasm, and that the kanosamine-6-phosphate thus formed interacts with GlcN-6-P synthase. Intracellular kanosamine phosphorylation is crucial for antifungal activity, as was demonstrated by the apparent inability of kanosamine to inhibit GlcN-6-P synthase and by the lack of antifungal activity of kanosamine-6-phosphate.
GlcN-6-P synthase has been already proposed as a potential target in antifungal chemotherapy [27] . Rationally designed oligopeptides, containing N 3 -(4-methoxyfumaroyl)-L-2,3-diaminopropanoic acid (FMDP), show promising antifungal in vitro and in vivo activity [28] . Unfortunately, their poor stability in serum [29] precluded possible further development as potential drugs. The anti-candidal activity of kanosamine is obviously very poor and this antibiotic cannot be considered as a drug candidate. However, we believe that the mechanism of its action could be exploited as a molecular basis for the rational design of a new class of GlcN-6-P synthase inhibitors as potential antifungals, active also against multidrug-resistant fungi. As a phosphorylation was obviously the step limiting the anti-candidal activity of kanosamine, it seems that further studies should be focused on modi cations of aminosugar analogues enhancing the recognition of these compounds by phosphorylating enzyme(s).
